Global Ischemic Stroke Drugs Market Size
Ischemic Stroke Drugs Market is expected to reach US$ 14.7 billion by 2034, growing at a compound annual growth rate of 4.5% from its 2024 valuation of US$ 9.5 billion.
An ischemic stroke is a medical emergency because it causes parts of the brain's blood supply to become blocked or reduced, which causes brain cells to die from a lack of oxygen. The symptoms include difficulty speaking, understanding, numbness, weakness, headache, difficulty walking, and difficulty seeing. Emergency medical attention is needed. One common term for reduced blood flow is ischemia. Among the most common causes of ischemic stroke are obesity, diabetes, hypertension, and smoking. Getting enough sleep and monitoring blood pressure are two aspects of hypertension patients' self-monitoring practices. Growing patient awareness and an aging population will aid in the development of more ischemic stroke medications.